The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
1 Alexandra Road
Farnborough, Hampshire GU14 6BU United Kingdom
44 (0)1252 546100
44 (0)1252 377140
The Anaphylaxis Campaign (AC) is a health organization in the United Kingdom dedicated to providing information, support, and guidance concerning anaphylaxis. Established in 1994, the campaign is committed to raising awareness in the food industry and within the healthcare communities to ensure optimum provision of information to, and treatment of, affected individuals. Anaphylaxis is a severe allergic reaction upon exposure to certain foods, drugs, chemicals, or insect stings. The condition occurs due to an over-reaction of the body's immune system in response to a previously encountered allergen. Within minutes, in some cases seconds, affected individuals may experience flushing of the skin; hives; swelling of the mouth and throat; difficulty speaking, swallowing, and/or breathing; nausea and vomiting; low blood pressure (hypotension); irregular heart beat (arrhythmia); and/or collapse and unconsciousness. The Anaphylaxis Campaign promotes research, provides a variety of educational materials, and has a web site.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.